HIV-1 Vpr interacts with a human 34-kDa mov34 homologue, a cellular factor linked to the G2/M phase transition of the mammalian cell cycle

被引:90
作者
Mahalingam, S [1 ]
Ayyavoo, V [1 ]
Patel, M [1 ]
Kieber-Emmons, T [1 ]
Kao, GD [1 ]
Muschel, RJ [1 ]
Weiner, DB [1 ]
机构
[1] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA
关键词
D O I
10.1073/pnas.95.7.3419
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Several important and possibly interrelated functions have been identified for the HIV-1 accessory gene product Vpr, These include import of the HIV reverse transcription complex into the nucleus of nondividing cells, cellular differentiation including cell cycle arrest at the G(2)/M phase border, immune suppression, and enhancement of virus replication, We have cloned a candidate Vpr ligand, termed human Vpr interacting protein (hVIP/MOV34), by using a yeast two-hybrid assay, This gene is homologous to a simultaneously identified 34-kDa human mov34 homologue, The MOV34 family includes proteins that function as transcriptional and proteolytic regulators of cell growth and differentiation. We demonstrate direct interactions between the putative ligand hVIP/MOV34 and Vpr in vitro and in vivo. hVIP/MOV34 localizes to the nucleus and appears to function as a component of the cell cycle cascade. We observe an association between the induction of cell cycle arrest at the G(2)/M phase border by Vpr and a change in the subcellular localization of hVIP/MOV34 from a nuclear to a perinuclear localization, This was further associated with the inhibition of maturation promoting factor-associated histone HI kinase activity, We conclude that hVIP/MOV34 is involved in the regulation of the cell cycle and a likely cellular cofactor for HIV-1 Vpr.
引用
收藏
页码:3419 / 3424
页数:6
相关论文
共 42 条
[1]   GENERATION AND CHARACTERIZATION OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 MUTANTS [J].
ADACHI, A ;
ONO, N ;
SAKAI, H ;
OGAWA, K ;
SHIBATA, R ;
KIYOMASU, T ;
MASUIKE, H ;
UEDA, S .
ARCHIVES OF VIROLOGY, 1991, 117 (1-2) :45-58
[2]   BIOLOGICAL CHARACTERIZATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 AND TYPE-2 MUTANTS IN HUMAN PERIPHERAL-BLOOD MONONUCLEAR-CELLS [J].
AKARI, H ;
SAKURAGI, J ;
TAKEBE, Y ;
TOMONAGA, K ;
KAWAMURA, M ;
FUKASAWA, M ;
MIURA, T ;
SHINJO, T ;
HAYAMI, M .
ARCHIVES OF VIROLOGY, 1992, 123 (1-2) :157-167
[3]   BASIC LOCAL ALIGNMENT SEARCH TOOL [J].
ALTSCHUL, SF ;
GISH, W ;
MILLER, W ;
MYERS, EW ;
LIPMAN, DJ .
JOURNAL OF MOLECULAR BIOLOGY, 1990, 215 (03) :403-410
[4]   REV IS NECESSARY FOR TRANSLATION BUT NOT CYTOPLASMIC ACCUMULATION OF HIV-1 VIF, VPR, AND ENV/VPU-2 RNAS [J].
ARRIGO, SJ ;
CHEN, ISY .
GENES & DEVELOPMENT, 1991, 5 (05) :808-819
[5]   Structure of cDNAs encoding human eukaryotic initiation factor 3 subunits - Possible roles in RNA binding and macromolecular assembly [J].
Asano, K ;
Vornlocher, HP ;
RichterCook, NJ ;
Merrick, WC ;
Hinnebusch, AG ;
Hershey, JWB .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (43) :27042-27052
[6]   HIV-1 Vpr suppresses immune activation and apoptosis through regulation of nuclear factor kappa B [J].
Ayyavoo, V ;
Mahboubi, A ;
Mahalingam, S ;
Ramalingam, R ;
Kudchodkar, S ;
Williams, WV ;
Green, DR ;
Weiner, DB .
NATURE MEDICINE, 1997, 3 (10) :1117-1123
[7]   DISTINCT EFFECTS IN PRIMARY MACROPHAGES AND LYMPHOCYTES OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ACCESSORY GENES VPR, VPU, AND NEF - MUTATIONAL ANALYSIS OF A PRIMARY HIV-1 ISOLATE [J].
BALLIET, JW ;
KOLSON, DL ;
EIGER, G ;
KIM, FM ;
MCGANN, KA ;
SRINIVASAN, A ;
COLLMAN, R .
VIROLOGY, 1994, 200 (02) :623-631
[8]   ANTISENSE PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES TARGETED TO THE VPR GENE INHIBIT HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REPLICATION IN PRIMARY HUMAN MACROPHAGES [J].
BALOTTA, C ;
LUSSO, P ;
CROWLEY, R ;
GALLO, RC ;
FRANCHINI, G .
JOURNAL OF VIROLOGY, 1993, 67 (07) :4409-4414
[9]  
BOOCHER RN, 1989, CELL, V58, P485
[10]   Human immunodeficiency virus type 1 Vpr protein binds to the uracil DNA glycosylase DNA repair enzyme [J].
Bouhamdan, M ;
Benichou, S ;
Rey, F ;
Navarro, JM ;
Agostini, I ;
Spire, B ;
Camonis, J ;
Slupphaug, G ;
Vigne, R ;
Benarous, R ;
Sire, J .
JOURNAL OF VIROLOGY, 1996, 70 (02) :697-704